Home Cart Sign in  
Chemical Structure| 2036272-55-4 Chemical Structure| 2036272-55-4

Structure of ALC-0315
CAS No.: 2036272-55-4

Chemical Structure| 2036272-55-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

ALC-0315, a cationic lipid, is a potent siRNA delivery vehicle. It can be used to form LNPs.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Onuma, Haruno ; Shimizu, Rina ; Suzuki, Yuichi ; Sato, Mina ; Harashima, Hideyoshi ; Sato, Yusuke

Abstract: The delivery of the CRISPR/Cas ribonucleoprotein (RNP) has received attention for clinical applications owing to its high efficiency with few off-target effects. Lipid nanoparticles (LNPs) are potential non-viral vectors for the delivery of RNPs. Herein, we report the engineering of a branched scaffold structure of ionizable lipids for hepatic delivery of RNPs. Both the total carbon number and branching position were critical for the functional delivery of RNPs. The optimal ionizable lipid exhibited a more than 98% reduction in transthyretin protein after a single dose with no obvious signs of toxicity. Mechanistic study has revealed that optimal LNPs have a unique “flower-like structure” that depends on both the lipid structure and the payload and that these LNPs accumulate in hepatocytes in an apolipoprotein E-independent manner. These results represent a major step toward the realization of in vivo genome editing therapy via RNP delivery using chemically synthesizable LNP formulations.

Keywords: genome editing ; ribonucleoprotein ; lipid nanoparticles ; ionizable lipid ; scaffold ; liver

Purchased from AmBeed:

Alternative Products

Product Details of ALC-0315

CAS No. :2036272-55-4
Formula : C48H95NO5
M.W : 766.27
SMILES Code : O=C(OCCCCCCN(CCCCO)CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)C(CCCCCC)CCCCCCCC
MDL No. :MFCD33402175
InChI Key :QGWBEETXHOVFQS-UHFFFAOYSA-N
Pubchem ID :122666778

Safety of ALC-0315

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Isoform Comparison

Biological Activity

Description
ALC-0315 is an ionizable aminolipid responsible for mRNA compaction, aiding in mRNA cellular delivery and its cytoplasmic release through suspected endosomal destabilization. ALC-0315 can be utilized to form lipid nanoparticle (LNP) delivery vehicles, which have been employed in mRNA COVID-19 vaccine research [1].

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.30mL

0.26mL

0.13mL

6.53mL

1.30mL

0.65mL

13.05mL

2.61mL

1.30mL

References

 

Historical Records

Categories